Completed PHASE2 INTERVENTIONAL NCT00004409

Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease

Sponsor: State University of New York

Interventions collagenase

Updated 5 times since 2017 Last updated: Mar 24, 2015 Started: Aug 31, 1995 Completion: Apr 30, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00004409, this PHASE2 trial focuses on Dupuytren's Contracture and remains completed. Sponsored by State University of New York, it has been updated 5 times since 1995, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Aug 1995

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

State University of New York

Data source: FDA Office of Orphan Products Development

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Palo Alto, United States
• Stony Brook, United States